A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
Infekt͡s︡ii͡a︡ i immunitet, 2021-04, Vol.11 (2), p.283-296 [Peer Reviewed Journal]ISSN: 2220-7619 ;EISSN: 2313-7398 ;DOI: 10.15789/2220-7619-ASB-1699
Full text available